KD025
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for KD025, covering 2021-09-13 to 2024-12-12. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy [Phase 2]